Clinical Trial

Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated October 29, 2025 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
Compare the efficacy and tolerability of IRE in combination with either FOLFIRINOX or gemcitabine in patients with locally advanced pancreatic cancer.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2018-03-23; most recent amendment 2025-10-27.
Status change: Not Yet Recruiting → Recruiting 2018-09-28
Trial Details
NCT Number NCT03484299
Lead Sponsor University of Louisville
Conditions Pancreas Cancer
Enrollment 20 participants
Start Date 2018-05-30
Primary Completion 2026-07-31 (estimated)
Study Completion 2027-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-29